Genetic and epigenetic factors in prediction of response to neoadjuvant chemoradiotherapy and clinical outcomes in rectal adenocarcinoma
Investigates whether molecular features of Jass classification predict response to neoadjuvant CRT
Jeremy Williamson's short paper presentation at Tripartite 2014